Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
Acticor Biotech Obtains "PRIME" Status From the European Medicines Agency for Glenzocimab in the Treatment of Stroke
ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT), a clinical-stage biotechnology company developing innovative drugs for the […]
Oncoustics Closes New Funding to Advance its AI Innovations in Ultrasound and Address Huge Unmet Clinical Needs in Liver Disease
Oncoustics (http://www.oncoustics.com), the leader in ultrasound-based tissue characterization solutions announces the initial close of a […]
Alpenglow Biosciences and Coreplus Partner Together to Bring 3D Spatial Biology to Clinical Research and Development
Alpenglow Biosciences (Alpenglow), developers of an innovative end-to-end 3D spatial biology platform, have announced a […]
Moderna Announces First Participant Dosed in a Phase 1 Trial of Its Nipah Virus mRNA Vaccine, mRNA-1215
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Tampa General Hospital Offers New Treatment Option for Recurrent Brain Cancer to Improve Quality of Life
Tampa General Hospital and USF Health Morsani College of Medicine physicians are the first in Hillsborough County to bring patients […]
Orexo’s Nasal Adrenaline Rescue Medication OX640 Enters Clinical Development
Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces it has successfully initiated the first explorative human clinical study […]
Faeth Therapeutics Raises $47 Million to Advance Clinical Trials and Feed the Fight Against Cancer
Faeth Therapeutics, a cancer metabolism company, today announced the closing of a $47 million Series A round […]
PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device
PreventionGenetics, a subsidiary of Exact Sciences Corp., announced today that it was recently granted marketing […]
3Spine, Inc. Completes First US Surgeries
3Spine, Inc., a medical device company developing total joint replacement for the lumbar spine, today […]
Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma
Antengene Corporation Limited (“Antengene“ SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more